Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
— Dr. Rock to support Cartography in the translation of tumor-specific targets into therapeutics, with initial focus on its lead program for colorectal cancer (CRC) — SOUTH SAN FRANCISCO, February 7, 2024 Cartography Biosciences, an oncology company advancing a...
Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
—Newly appointed members Tara Arvedson, Ph.D., and Janine Schuurman, Ph.D., to support Cartography in the advancement of first-in-class precision cancer immunotherapies— May 31, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Cartography...